140 related articles for article (PubMed ID: 34610169)
1. Epithelioid inflammatory myofibroblastic sarcomas are not exclusive to ventral cavity sites.
Zilla ML; Khoshnoodi P; Bailey NG; Herradura A; Lee SJ; John I
Histopathology; 2022 Feb; 80(3):610-612. PubMed ID: 34610169
[No Abstract] [Full Text] [Related]
2. Epithelioid Inflammatory Myofibroblastic Sarcoma.
Hallin M; Thway K
Int J Surg Pathol; 2019 Feb; 27(1):69-71. PubMed ID: 29623737
[No Abstract] [Full Text] [Related]
3. Primary Cutaneous Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring RANBP2-ALK Fusion: Report of an Exceptional Case.
Gadeyne L; Creytens D; Dekeyser S; Van der Meulen J; Haspeslagh M
Am J Dermatopathol; 2022 Apr; 44(4):302-305. PubMed ID: 34816804
[TBL] [Abstract][Full Text] [Related]
4. Epithelioid inflammatory myofibroblastic sarcoma arising in the pleural cavity.
Kozu Y; Isaka M; Ohde Y; Takeuchi K; Nakajima T
Gen Thorac Cardiovasc Surg; 2014 Mar; 62(3):191-4. PubMed ID: 23345154
[TBL] [Abstract][Full Text] [Related]
5. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
[TBL] [Abstract][Full Text] [Related]
6. Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.
Liu Q; Kan Y; Zhao Y; He H; Kong L
Int J Clin Exp Pathol; 2015; 8(11):15328-32. PubMed ID: 26823889
[TBL] [Abstract][Full Text] [Related]
7. Epithelioid inflammatory myofibroblastic sarcoma with recurrence after extensive resection: significant clinicopathologic characteristics of a rare aggressive soft tissue neoplasm.
Zhou J; Jiang G; Zhang D; Zhang L; Xu J; Li S; Li W; Ma Y; Zhao A; Zhao Z
Int J Clin Exp Pathol; 2015; 8(5):5803-7. PubMed ID: 26191301
[TBL] [Abstract][Full Text] [Related]
8. CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma.
Fordham AM; Xie J; Gifford AJ; Wadham C; Morgan LT; Mould EVA; Fadia M; Zhai L; Massudi H; Ali ZS; Marshall GM; Lukeis RE; Fletcher JI; MacKenzie KL; Trahair TN
Br J Cancer; 2020 Sep; 123(7):1101-1113. PubMed ID: 32684628
[TBL] [Abstract][Full Text] [Related]
9. Epithelioid inflammatory myofibroblastic sarcoma in abdominal cavity: a case report and review of literature.
Wu H; Meng YH; Lu P; Ning HY; Hong L; Kang XL; Duan MG
Int J Clin Exp Pathol; 2015; 8(4):4213-9. PubMed ID: 26097614
[TBL] [Abstract][Full Text] [Related]
10. [Inflammatory myofibroblastic tumor].
Leuschner I
Pathologe; 2010 Mar; 31(2):106-8. PubMed ID: 20063099
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid Fibrous Histiocytoma: A Concise Review.
Felty CC; Linos K
Am J Dermatopathol; 2019 Dec; 41(12):879-883. PubMed ID: 30289773
[TBL] [Abstract][Full Text] [Related]
12. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
Parker BM; Parker JV; Lymperopoulos A; Konda V
J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
[TBL] [Abstract][Full Text] [Related]
13. Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.
Chopra S; Maloney N; Wang WL
Brain Tumor Pathol; 2022 Jan; 39(1):35-42. PubMed ID: 34743247
[TBL] [Abstract][Full Text] [Related]
14. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
[TBL] [Abstract][Full Text] [Related]
15. Epithelioid angiomyolipoma: a morphologically distinct variant that mimics a variety of intra-abdominal neoplasms.
Mete O; van der Kwast TH
Arch Pathol Lab Med; 2011 May; 135(5):665-70. PubMed ID: 21526965
[TBL] [Abstract][Full Text] [Related]
16. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract][Full Text] [Related]
17. Metastatic Sclerosing Epithelioid Fibrosarcoma in Bone Marrow.
Asakra R; Zaidi S; Thway K
Int J Surg Pathol; 2017 Dec; 25(8):702-704. PubMed ID: 28697683
[TBL] [Abstract][Full Text] [Related]
18. Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation.
Machado I; López-Soto MV; Rubio L; Navarro L; Llombart-Bosch A
Diagn Cytopathol; 2015 May; 43(5):421-6. PubMed ID: 25693574
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review.
Li J; Yin WH; Takeuchi K; Guan H; Huang YH; Chan JK
Diagn Pathol; 2013 Sep; 8():147. PubMed ID: 24034896
[TBL] [Abstract][Full Text] [Related]
20. Perivascular epithelioid cell tumour (PEComa) of the soft tissue.
Mai KT; Belanger EC
Pathology; 2006 Oct; 38(5):415-20. PubMed ID: 17008279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
